Search Results - "Hohlbaum, A"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies by Schönfeld, D, Matschiner, G, Chatwell, L, Trentmann, S, Gille, H, Hülsmeyer, M, Brown, N, Kaye, P.M, Schlehuber, S, Hohlbaum, A.M, Skerra, A

    “…Biomolecular reagents that enable the specific molecular recognition of proteins play a crucial role in basic research as well as medicine. Up to now,…”
    Get full text
    Journal Article
  2. 2

    Fas Ligand Engagement of Resident Peritoneal Macrophages In Vivo Induces Apoptosis and the Production of Neutrophil Chemotactic Factors by Hohlbaum, Andreas M, Gregory, Meredith S, Ju, Shyr-Te, Marshak-Rothstein, Ann

    Published in The Journal of immunology (1950) (01-12-2001)
    “…Fas ligand (FasL) is a potent proapoptotic type-II transmembrane protein that can cause cell death in Fas+ target populations. Despite the presumed "silent"…”
    Get full text
    Journal Article
  3. 3

    Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors by Leadbetter, Elizabeth A, Rifkin, Ian R, Hohlbaum, Andreas M, Beaudette, Britte C, Shlomchik, Mark J, Marshak-Rothstein, Ann

    Published in Nature (London) (11-04-2002)
    “…Autoreactive B cells are present in the lymphoid tissues of healthy individuals, but typically remain quiescent. When this homeostasis is perturbed, the…”
    Get full text
    Journal Article
  4. 4

    Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival by Hohlbaum, A M, Moe, S, Marshak-Rothstein, A

    Published in The Journal of experimental medicine (03-04-2000)
    “…Fas ligand (FasL) has been shown to mediate both apoptotic and inflammatory reactions. To rigorously assess the physiological role of different forms of the…”
    Get full text
    Journal Article
  5. 5

    CD95 (Fas) Ligand-Expressing Vesicles Display Antibody-Mediated, FcR-Dependent Enhancement of Cytotoxicity by Jodo, Satoshi, Hohlbaum, Andreas M, Xiao, Sheng, Chan, Derek, Strehlow, David, Sherr, David H, Marshak-Rothstein, Ann, Ju, Shyr-Te

    Published in The Journal of immunology (1950) (15-11-2000)
    “…Bioactive Fas ligand (FasL)-expressing vesicles were generated (vesicle preparation, VP) from two cell lines overexpressing FasL. The effect of NOK-1 anti-FasL…”
    Get full text
    Journal Article
  6. 6

    Fas-Ligand—Iron Fist or Achilles' Heel? by Hohlbaum, Andreas M., Saff, Rebecca R., Marshak-Rothstein, Ann

    Published in Clinical Immunology (01-04-2002)
    “…Experimental and physiological expression of the pro-apoptotic molecule Fas-ligand can induce inflammation under certain conditions. Discussed here are the…”
    Get full text
    Book Review Journal Article
  7. 7
  8. 8

    The B cell repertoire of patients with rheumatoid arthritis. Frequencies and specificities of peripheral blood B cells reacting with human IgG, human collagens, a mycobacterial heat shock protein and other antigens by RUDOLPHI, U., HOHLBAUM, A., LANG, B., PETER, H. H., MELCHERS, I.

    Published in Clinical and experimental immunology (01-06-1993)
    “…SUMMARY Using a potent in vitro limiting dilution culture system, we have activated human peripheral blood B cells to proliferate and to differentiate into…”
    Get full text
    Journal Article
  9. 9

    Structure and expression of a non-polyadenylated ribosome bound transcript carrying the sequence of human ribosomal protein L7 mRNA in antisense orientation by Hohlbaum, A M, Krawinkel, U, Hemmerich, P

    Published in Biological chemistry (01-08-1998)
    “…Human ribosomal protein L7 has been shown to be involved in the control of translation of distinct mRNAs. In this study we report the existence of an RNA…”
    Get more information
    Journal Article
  10. 10

    Apoptosis-inducing membrane vesicles. A novel agent with unique properties by Jodo, S, Xiao, S, Hohlbaum, A, Strehlow, D, Marshak-Rothstein, A, Ju, S T

    Published in The Journal of biological chemistry (26-10-2001)
    “…The CD95 ligand (FasL) transmembrane protein is found on activated T cells and cells outside the immune system. A well-known turnover process of membrane FasL…”
    Get full text
    Journal Article
  11. 11

    Activation-Induced Cell Death Limits Effector Function of CD4 Tumor-Specific T Cells by Saff, Rebecca R, Spanjaard, Elena S, Hohlbaum, Andreas M, Marshak-Rothstein, Ann

    Published in The Journal of immunology (1950) (01-06-2004)
    “…A number of studies have documented a critical role for tumor-specific CD4(+) cells in the augmentation of immunotherapeutic effector mechanisms. However, in…”
    Get full text
    Journal Article
  12. 12